🇺🇸 FDA
Pipeline program

Methotrexate

2018-FSMYK-001

Unknown small_molecule completed

Quick answer

Methotrexate for Knee Osteoarthritis is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Knee Osteoarthritis
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials